When was Ambitious Bio founded?

Ambitious Bio was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is Ambitious Bio located?

Ambitious Bio is headquartered in Cambridge, United States.

Is Ambitious Bio a funded company?

Ambitious Bio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Sep 22, 2026.

When was the latest funding round of Ambitious Bio?

Ambitious Bio's latest funding was a $***** Seed round on Sep 22, 2026, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does Ambitious Bio rank among its competitors?

Ambitious Bio ranks 99th amongst 128 active competitors, of which 40 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ambitious Bio, which secured $6M in Sep, 2026.

Who are the top competitors of Ambitious Bio?

Ambitious Bio's top competitors include Biognosys, Peptris and Talus. Among them, Ambitious Bio secured the most recent funding round in September, 2026.

Ambitious Bio - 2026 Company Profile, Funding & Competitors

Ambitious Bio is a seed company based in Cambridge (United States), founded in 2025. It operates as a Developer of molecular protein mapping platforms for biological research analysis. Ambitious Bio has raised $6M in funding. The company has 128 active competitors, including 40 funded and 10 that have exited. Its top competitors include companies like Biognosys, Peptris and Talus.

Company Details

Developer of molecular protein mapping platforms for biological research analysis. Technology quantifies protein composition and spatial organization within human tissues to create detailed inventories of molecular components. These tools provide contextual data regarding biological structures to support the development of computational models for health research.

Key Metrics

Founded Year

2025

Location

Cambridge, United States

Stage

Seed

Total Funding

$6M in 1 round

Latest Funding Round

Seed, Sep 22, 2026, $*****

Ranked

99^th among 128 active competitors

Similar Companies

Biognosys & 158 more

View Ambitious Bio's full profile

Ambitious Bio has raised a total funding of $6M over 1 round.

Here is the list of recent funding rounds of Ambitious Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 22, 2026	6395944	Seed	8842932	5322079	4049186	8513427

Access funding benchmarks and valuations. Sign up today!

View details of Ambitious Bio's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ambitious Bio include Biognosys, Peptris and Talus. Here is the list of Top 10 competitors of Ambitious Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Syngenta Group, Zurcher Kantonalbank & 6 others	63/100
2nd	Peptris 2019, Bengaluru (India), Series A	Provider of AI-based proteomic data analysis software for drug discovery	$9.17M	Speciale Invest, Indian Angel Network Fund ... & 46 others	61/100
3rd	Talus 2020, Seattle (United States), Seed	Provider of drug discovery platform for gene regulators	$19.8M	Fifty Years, Y Combinator & 11 others	60/100
4th	Unnatural Products 2016, Santa Cruz (United States), Series B	Developer of computational biology techniques platform to engineer peptides for undruggable targets	$83M	Artis Ventures, Merck Global Health Innovation Fund ... & 17 others	57/100
5th	BridGene Biosciences 2018, Sunnyvale (United States), Series B	Developer of small-molecule drugs for the treatment of cancer	$78.5M	Deyi Capital, Lapam Capital & 8 others	57/100
6th	Aureka Biotechnologies 2023, Laguna Hills (United States), Series B	Biotech company digitizing therapeutic discovery to manage human health	$200M	5Y Capital, Qiming Venture Partners & 6 others	55/100
7th	ProteinSimple 2004, San Jose (United States), Acquired	Provider tools to help researchers with protein analysis	$94.3M	Lansing Brown Investments, Royal Bank of Canada ... & 10 others	54/100
8th	Avenue Biosciences 2023, Palo Alto (United States), Seed	Biotechnology company that employs protein engineering solutions	$9.94M	Balnord, Voima Ventures & 4 others	54/100
9th	Cyrus Biotechnology 2014, Seattle (United States), Series B	Developer of cloud-based protein-modelling software for drug discovery	$32M	Trinity Ventures, Agent Capital & 11 others	53/100
10th	HeliXon 2009, China, Series A	Developer of an integrated platform for protein therapeutic discovery and optimization	$74.7M	5Y Capital, Hillhouse & 4 others	51/100
99th	Ambitious Bio 2025, Cambridge (United States), Seed	Developer of molecular protein mapping platforms for biological research analysis	$6M	-	21/100